Compass Therapeutics CMPX
NASDAQ CMPX
$0.83 -0.01 (-0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Compass Therapeutics (CMPX) Long-Term Deferred Tax (2021 - 2025)

Updated

Analysis

Compass Therapeutics (CMPX) Long-Term Deferred Tax (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Compass Therapeutics 151.27 Mn -597.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.56 Mn
Dec 31, 2024 1.90 Mn
Dec 31, 2023 485,000.00
Dec 31, 2022 809,000.00
Dec 31, 2021 1.17 Mn
API Access

Compass Therapeutics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=CMPX&period=max&api_key=YOUR_API_KEY